Advertisement
The Journal of Pain
US Association for the Study of Pain
Advanced searchSave search
Letter to the Editor| Volume 13, ISSUE 10, P1028, October 2012

Emerging New Therapeutic Options for Paclitaxel-Induced Neuropathic Pain

DOI:https://doi.org/10.1016/j.jpain.2012.07.004
Emerging New Therapeutic Options for Paclitaxel-Induced Neuropathic Pain
Previous ArticleRelationship Between Temporomandibular Disorders, Widespread Palpation Tenderness, and Multiple Pain Conditions: A Case-Control Study
Next ArticleMasthead
      The recent article by Zhang et al
      • Zhang H.
      • Yoon S.Y.
      • Zhang H.
      • Dougherty P.M.
      Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathy.
      J Pain. 2012; 13: 293-303
      regarding the pathogenesis of paclitaxel-induced painful neuropathy provided for highly interesting reading. Interestingly, the past few years have seen the emergence of a number of novel new agents that are increasingly proving to be highly effective in the management of paclitaxel-induced painful neuropathy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Burgos E.
        • Gomez-Nicola D.
        • Pascual D.
        • Martin M.I.
        • Nieto-Sampedro M.
        • Goicoechea C.
        Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.
        Eur J Pharmacol. 2012; 682: 62-72
        View in Article
        • Chentanez V.
        • Thanomsridejchai N.
        • Duangmardphon N.
        • Agthong S.
        • Kaewsema A.
        • Huanmanop T.
        • Maneesri S.
        Ganglioside GM1 (porcine) ameliorates paclitaxel-induced neuropathy in rats.
        J Med Assoc Thai. 2009; 92: 50-57
        View in Article
        • Costa R.
        • Motta E.M.
        • Dutra R.C.
        • Manjavachi M.N.
        • Bento A.F.
        • Malinsky F.R.
        • Pesquero J.B.
        • Calixto J.B.
        Anti-nociceptive effect of kinin B and B receptor antagonists on peripheral neuropathy induced by paclitaxel in mice.
        Br J Pharmacol. 2011; 164: 681-693
        View in Article
        • Matsumura T.
        • Imamura H.
        • Kishimoto T.
        • Miyazaki Y.
        • Fujii C.
        • Fujino M.
        • Yasui Y.
        • Anami S.
        • Sumita R.
        • Takada N.
        • Fujita Y.
        • Furukawa H.
        A case of paclitaxel-induced peripheral neuropathy successfully treated by H2-blocker, lafutidine.
        Gan To Kagaku Ryoho. 2009; 36: 1565-1568
        View in Article
        • Meng X.
        • Zhang Y.
        • Li A.
        • Xin J.
        • Lao L.
        • Ren K.
        • Berman B.M.
        • Tan M.
        • Zhang R.X.
        The effects of opioid receptor antagonists on electroacupuncture-produced anti-allodynia/hyperalgesia in rats with paclitaxel-evoked peripheral neuropathy.
        Brain Res. 2011; 1414: 58-65
        View in Article
        • Pascual D.
        • Goicoechea C.
        • Suardiaz M.
        • Martin M.I.
        A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats.
        Pain. 2005; 118: 23-34
        View in Article
        • Pourmohammadi N.
        • Alimoradi H.
        • Mehr S.E.
        • Hassanzadeh G.
        • Hadian M.R.
        • Sharifzadeh M.
        • Bakhtiarian A.
        • Dehpour A.R.
        Lithium attenuates peripheral neuropathy induced by paclitaxel in rats.
        Basic Clin Pharmacol Toxicol. 2012; 110: 231-237
        View in Article
        • Xiao W.H.
        • Zheng F.Y.
        • Bennett G.J.
        • Bordet T.
        • Pruss R.M.
        Olesoxime (cholest-4-en-3-one, oxime): Analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel.
        Pain. 2009; 147: 202-209
        View in Article
        • Zhang H.
        • Yoon S.Y.
        • Zhang H.
        • Dougherty P.M.
        Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathy.
        J Pain. 2012; 13: 293-303
        View in Article

      Article info

      Identification

      DOI: https://doi.org/10.1016/j.jpain.2012.07.004

      Copyright

      © 2012 American Pain Society. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX